These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 15387447)
41. [Evaluation of the analytical performance characteristics of NT-proBNP immunoassay on dimension RxL-HM (Dade Behring)]. Benoit MO; Dautezac F; Taccoen M; Paul JL Ann Biol Clin (Paris); 2005; 63(4):411-6. PubMed ID: 16061439 [TBL] [Abstract][Full Text] [Related]
42. Determinants of absolute and relative exercise-induced changes in B-type natriuretic peptides. Maeder MT; Staub D; Surnier Y; Reichlin T; Noveanu M; Breidthardt T; Potocki M; Schaub N; Conen D; Mueller C Int J Cardiol; 2011 Mar; 147(3):409-15. PubMed ID: 19897258 [TBL] [Abstract][Full Text] [Related]
43. Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure. Fitzgerald RL; Cremo R; Gardetto N; Chiu A; Clopton P; Bhalla V; Maisel AS Am Heart J; 2005 Sep; 150(3):471-7. PubMed ID: 16169326 [TBL] [Abstract][Full Text] [Related]
44. Long-term stability of endogenous B-type natriuretic peptide after storage at -20 degrees C or -80 degrees C. Pereira M; Azevedo A; Severo M; Barros H Clin Chem Lab Med; 2008; 46(8):1171-4. PubMed ID: 18588432 [TBL] [Abstract][Full Text] [Related]
46. [Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population]. El Mahmoud R; Alibay Y; Brun-Ney D; Boulard JC; Dubourg O; Puy H; Jondeau G Arch Mal Coeur Vaiss; 2006 Mar; 99(3):201-7. PubMed ID: 16618022 [TBL] [Abstract][Full Text] [Related]
48. Risk of cardiovascular death in elderly patients with possible heart failure. B-type natriuretic peptide (BNP) and the aminoterminal fragment of ProBNP (N-terminal proBNP) as prognostic indicators in a 6-year follow-up of a primary care population. Alehagen U; Lindstedt G; Levin LA; Dahlström U Int J Cardiol; 2005 Apr; 100(1):125-33. PubMed ID: 15820295 [TBL] [Abstract][Full Text] [Related]
49. Effects of sample handling on serum N-terminal proB-type natriuretic peptide concentration in normal dogs and dogs with heart disease. Collins SA; Patteson MW; Connolly DJ; Brodbelt DC; Torrance AG; Harris JD J Vet Cardiol; 2010 Apr; 12(1):41-8. PubMed ID: 20226751 [TBL] [Abstract][Full Text] [Related]
50. Prognostic value of B-type natriuretic peptide and its amino-terminal proBNP fragment for cardiovascular events with stratification by renal function. Horii M; Matsumoto T; Uemura S; Sugawara Y; Takitsume A; Ueda T; Nakagawa H; Nishida T; Soeda T; Okayama S; Somekawa S; Ishigami K; Takeda Y; Kawata H; Kawakami R; Saito Y J Cardiol; 2013 Jun; 61(6):410-6. PubMed ID: 23618914 [TBL] [Abstract][Full Text] [Related]
52. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Heeschen C; Hamm CW; Mitrovic V; Lantelme NH; White HD; Circulation; 2004 Nov; 110(20):3206-12. PubMed ID: 15533869 [TBL] [Abstract][Full Text] [Related]
53. Severe acute mountain sickness, brain natriuretic peptide and NT-proBNP in humans. Woods DR; Begley J; Stacey M; Smith C; Boos CJ; Hooper T; Hawkins A; Hodkinson P; Green N; Mellor A Acta Physiol (Oxf); 2012 Jul; 205(3):349-55. PubMed ID: 22222437 [TBL] [Abstract][Full Text] [Related]
54. BNP and NT-proBNP, predictors of 1-year mortality in nursing home residents. Barents M; Hillege HH; van der Horst IC; de Boer RA; Koster J; Muskiet FA; de Jongste MJ J Am Med Dir Assoc; 2008 Oct; 9(8):580-5. PubMed ID: 19083292 [TBL] [Abstract][Full Text] [Related]
55. The effect of glycosylation on plasma N-terminal proBNP-76 levels in patients with heart or renal failure. Nishikimi T; Ikeda M; Takeda Y; Ishimitsu T; Shibasaki I; Fukuda H; Kinoshita H; Nakagawa Y; Kuwahara K; Nakao K Heart; 2012 Jan; 98(2):152-61. PubMed ID: 21719557 [TBL] [Abstract][Full Text] [Related]
56. Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study. Prontera C; Zaninotto M; Giovannini S; Zucchelli GC; Pilo A; Sciacovelli L; Plebani M; Clerico A Clin Chem Lab Med; 2009; 47(6):762-8. PubMed ID: 19402791 [TBL] [Abstract][Full Text] [Related]
57. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery. Schouten O; Hoeks SE; Goei D; Bax JJ; Verhagen HJ; Poldermans D J Vasc Surg; 2009 Feb; 49(2):435-41; discussion 441-2. PubMed ID: 19028043 [TBL] [Abstract][Full Text] [Related]
58. [BNP or NT-proBNP: "that is the question"]. Lebrun C; Neuder Y; Pison C; Chouri N; Barnoud D; Belle L; Beaune G Ann Biol Clin (Paris); 2007; 65(5):533-8. PubMed ID: 17913672 [TBL] [Abstract][Full Text] [Related]
59. [Impact of acute fluid restriction on levels of natriuretic peptides in patients on a chronic dialysis program]. Oral I; Stejskal D; Loucký J; Sislák Z; Coufal Z; Mistrík J; Náplava R Vnitr Lek; 2004 Nov; 50(11):812-7. PubMed ID: 15648959 [TBL] [Abstract][Full Text] [Related]